Literature DB >> 33047719

[Association of CMTM5 gene expression with the risk of in-stent restenosis in patients with coronary artery disease after drug-eluting stent implantation and the effects and mechanisms of CMTM5 on human vascular endothelial cells].

T F Liu, T Lin, L H Ren, G P Li, J J Peng.   

Abstract

OBJECTIVE: To elucidate the correlation between CKLF-like marvel transmembrane domain containing member (CMTM5) gene and the risk of in-stent restenosis (ISR) with coronary artery disease (CAD) patients and to detect the effects and mechanisms of CMTM5-stimulated genes on human vascular endothelial cells (ECs) proliferation and migration.
METHODS: A total of 124 hospitalized patients in Shijitan Hospital were enrolled in this study. All the CAD patients were detected with platelet reactivity and grouped into two groups according to platelet reactivity; ISR was conformed by coronary angiography; RT-PCR method was used to detect CMTM5 gene expression; The CMTM5 over expression, reduction and control EC lines were established; Cell count, MTT, Brdu and flow cytometry methods were used to detect the proliferation of ECs, scratch and transwell experiments to test the migration of ECs, Western blot was used to detect signal path expressions.
RESULTS: CMTM5 gene expression in HAPR (High on aspirin platelet reactivity) group was 1.72 times compared with No-HAPR group, which was significantly higher than No-HAPR group. HAPR group ISR rate was 25.8% (8 cases), the incidence of No-HAPR ISR group was 9.7% (9 cases), and the results showed that in HAPR group, the incidence of ISR was significantly higher than that in No-HAPR group (P=0.04, OR=0.04, 95%CI=1.16-7.52), which showed that CMTM5 gene was significantly correlated with the risk of ISR. In HAPR group ISR rate was 25.8% (8 cases), the incidence of ISR in No-HAPR group was 9.7% (9 cases), and the results showed that the risk of ISR in HAPR group was significantly higher than that in No-HAPR group. All the results showed that CMTM5 was significantly correlated with the risk of ISR in CAD patients (P < 0.05). CMTM5 overexpression inhibited the proliferation and migration ability of ECs (P < 0.05), PI3K/Akt signaling pathways were involved in the role of regulation on ECs.
CONCLUSION: Our results revealed that CMTM5 gene was closely related with ISR, CMTM5 overexpression may repress ECs proliferation and migration through regulating PI3K-Akt signaling.

Entities:  

Keywords:  CKLF-like marvel transmembrane dimain containing member 5; Coronary artery diseases; In-stent restenosis; Platelet reactivity

Mesh:

Substances:

Year:  2020        PMID: 33047719      PMCID: PMC7653433     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  14 in total

Review 1.  Pathology of in-stent restenosis.

Authors:  R Virmani; A Farb
Journal:  Curr Opin Lipidol       Date:  1999-12       Impact factor: 4.776

Review 2.  Late stent thrombosis in brachytherapy: the role of long-term antiplatelet therapy.

Authors:  Paul Teirstein; John P Reilly
Journal:  J Invasive Cardiol       Date:  2002-03       Impact factor: 2.022

3.  Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation.

Authors:  Femi Philip
Journal:  J Am Coll Cardiol       Date:  2015-09-01       Impact factor: 24.094

4.  Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents.

Authors:  Pramod K Kuchulakanti; William W Chu; Rebecca Torguson; Patrick Ohlmann; Seung-Woon Rha; Leonardo C Clavijo; Sang-Wook Kim; Ahn Bui; Natalie Gevorkian; Zhenyi Xue; Kimberly Smith; Jana Fournadjieva; William O Suddath; Lowell F Satler; Augusto D Pichard; Kenneth M Kent; Ron Waksman
Journal:  Circulation       Date:  2006-02-20       Impact factor: 29.690

Review 5.  Treatment of coronary artery in-stent restenosis.

Authors:  Damianos G Kokkinidis; Stephen W Waldo; Ehrin J Armstrong
Journal:  Expert Rev Cardiovasc Ther       Date:  2017-01-31

6.  Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events.

Authors:  Deepak Voora; Derek Cyr; Joseph Lucas; Jen-Tsan Chi; Jennifer Dungan; Timothy A McCaffrey; Richard Katz; L Kristin Newby; William E Kraus; Richard C Becker; Thomas L Ortel; Geoffrey S Ginsburg
Journal:  J Am Coll Cardiol       Date:  2013-07-03       Impact factor: 24.094

Review 7.  Endothelial dysfunction: how can one intervene at the beginning of the cardiovascular continuum?

Authors:  Roland E Schmieder
Journal:  J Hypertens Suppl       Date:  2006-04

8.  Comparison between urinary 11-dehydrothromboxane B2 detection and platelet Light Transmission Aggregometry (LTA) assays for evaluating aspirin response in elderly patients with coronary artery disease.

Authors:  Tengfei Liu; Jingwei Zhang; Xiahuan Chen; Xueru Feng; Sidney W Fu; Timothy A McCaffrey; Meilin Liu
Journal:  Gene       Date:  2015-06-19       Impact factor: 3.688

9.  Heat shock protein 27 attenuates neointima formation and accelerates reendothelialization after arterial injury and stent implantation: importance of vascular endothelial growth factor up-regulation.

Authors:  Xiaoli Ma; Benjamin Hibbert; Melissa McNulty; Tieqiang Hu; Xiaoling Zhao; F Daniel Ramirez; Trevor Simard; Jacqueline S de Belleroche; Edward R O'Brien
Journal:  FASEB J       Date:  2013-10-18       Impact factor: 5.191

10.  [Association between CMTM5 gene rs723840 single nucleotide polymorphism and high on asprin platelet reactivity].

Authors:  Teng-fei Liu; Jing-wei Zhang; Xia-huan Chen; Xue-ru Feng; Zhong-sheng Bai; Mei-lin Liu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2015-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.